SOSV

SOSV, established in 1995 and headquartered in Princeton, New Jersey, is a global venture capital firm specializing in early-stage investments. It focuses on deep tech innovations in the health and environmental sectors, supporting founders with breakthrough technologies through its HAX and IndieBio startup development programs. SOSV provides resources, facilities, and lab equipment to accelerate product development and scale, with a track record of helping its portfolio companies secure subsequent funding rounds led by top-tier investors.

Hugh Bowen

Associate

Weichang Ge

Analyst

Bradford Higgins

Venture Partner

Katie Hoffman

General Partner

Mohan Iyer

General Partner

Benjamin Joffe

Partner

Ji Ke

Partner

Stephen McCann

CFO and General Partner

Carthach McCarthy

CFO

Paul Monaghan

Principal

Brian Murphy

Finance Director

Eric Ramsay

Analyst

Sabriya Stukes Ph.D

Partner

Past deals in Latvia

Alternative Plants

Seed Round in 2022
Alternative Plants, SIA is a biotechnology start-up based in Riga, Latvia, founded in 2017. The company specializes in the development of active ingredients derived from plant stem cell cultures, focusing on medicinal plants that are rare, endangered, or difficult to cultivate. This innovative technology allows for the sustainable and consistent production of cosmetic ingredients, primarily targeting the anti-aging and skin whitening markets. Clients include cosmetic manufacturers that incorporate these plant stem cell-derived substances as key ingredients in their products. While the current emphasis is on the cosmetic sector, the company aims to expand its technology to other markets, including functional foods, medical devices, and pharmaceuticals.

Alternative Plants

Seed Round in 2017
Alternative Plants, SIA is a biotechnology start-up based in Riga, Latvia, founded in 2017. The company specializes in the development of active ingredients derived from plant stem cell cultures, focusing on medicinal plants that are rare, endangered, or difficult to cultivate. This innovative technology allows for the sustainable and consistent production of cosmetic ingredients, primarily targeting the anti-aging and skin whitening markets. Clients include cosmetic manufacturers that incorporate these plant stem cell-derived substances as key ingredients in their products. While the current emphasis is on the cosmetic sector, the company aims to expand its technology to other markets, including functional foods, medical devices, and pharmaceuticals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.